Maturation modulates caspase-1-independent responses of dendritic cells to Anthrax lethal toxin

Cellular Microbiology
Núria ReigF Gisou van der Goot

Abstract

Anthrax lethal toxin (LT) contributes to the immune evasion strategy of Bacillus anthracis by impairing the function of cells of the immune system, such as macrophages and dendritic cells (DCs). Macrophages from certain inbred mice strains undergo rapid death upon LT treatment mediated by caspase-1 activation dependent on Nalp1b, an inflammasome component. Rapid LT-induced death is however, not observed in macrophages from human and many mouse strains. Here, we focused on the responses of various murine DCs to LT. Using a variety of knockout mice, we found that depending on the mouse strain, death of bone marrow-derived DCs and macrophages was mediated either by a fast Nalp1b and caspase-1-dependent, or by a slow caspase-1-independent pathway that was triggered by the impairment of MEK1/2 pathways. Caspase-1-independent death was observed in cells of different genetic backgrounds and interestingly occurred only in immature DCs. Maturation, triggered by different types of stimuli, led to full protection of DCs. These studies illustrate that the cellular damage inflicted by LT depends not only on the innate responses but also on the maturation stage of the cell, which modulates the more general caspase-1-independent responses.

References

Nov 1, 1989·The Journal of Experimental Medicine·E L Racoosin, J A Swanson
Jan 1, 1988·Methods in Enzymology·S H Leppla
Jan 1, 1993·Infection and Immunity·A M FriedlanderY Singh
May 23, 1998·Science·N S DuesberyG F Vande Woude
Nov 26, 1998·The Journal of Biological Chemistry·H HilbiA Zychlinsky
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D HershA Zychlinsky
Nov 24, 1999·The Journal of Biological Chemistry·J MasumotoJ Sagara
Oct 13, 2000·Molecular Microbiology·M A Brennan, B T Cookson
Nov 9, 2001·Nature·K A BradleyJ A Young
Mar 5, 2002·Nature Immunology·Michael Karin, Anning Lin
Apr 10, 2002·Cancer Immunology, Immunotherapy : CII·Andreas LundqvistPavel Pisa
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Jan 29, 2003·The Journal of Cell Biology·Laurence AbramiF Gisou van der Goot
Mar 5, 2003·Annual Review of Immunology·Ralph M SteinmanMichel C Nussenzweig
Apr 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Heather M ScobieJohn A T Young
May 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ozlem TüreciJuergen Hammer
Aug 2, 2003·Current Opinion in Cell Biology·Evelina Gatti, Philippe Pierre
Mar 24, 2004·Current Opinion in Microbiology·Mahtab Moayeri, Stephen H Leppla
Jun 10, 2004·Microbiology and Molecular Biology Reviews : MMBR·Philippe P Roux, John Blenis
Sep 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Huiming HonJoshy Jacob
Feb 1, 2005·Trends in Microbiology·Laurence AbramiF Gisou van der Goot
Feb 9, 2005·The Journal of Experimental Medicine·Silvia Rossi PaccaniCosima T Baldari
Mar 18, 2005·Annual Review of Immunology·E Sergio Trombetta, Ira Mellman
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jean-Nicolas TournierPierre L Goossens
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hui FangDavid M Frucht
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katherine C BrittinghamSina Bavari
Aug 10, 2005·The Journal of Infectious Diseases·Russell L DuringFrederick S Southwick

❮ Previous
Next ❯

Citations

Oct 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sun-Young JeongStanley N Cohen
Mar 24, 2009·Annual Review of Immunology·Fabio MartinonJürg Tschopp
Jan 1, 2010·Sensors·Gang Chen, Joao H F Pedra
Dec 31, 2011·Microbes and Infection·Mahtab MoayeriStephen H Leppla
Jul 30, 2009·Molecular Aspects of Medicine·Mahtab Moayeri, Stephen H Leppla
Jun 30, 2009·Molecular Aspects of Medicine·Jean-Nicolas TournierCosima T Baldari
Jul 22, 2015·Annual Review of Microbiology·Mahtab MoayeriShihui Liu
Mar 16, 2016·Toxins·Sarah FriebeJérôme Bürgi
Jul 3, 2010·The American Journal of Pathology·Stefan M MuehlbauerJürgen Brojatsch
Apr 7, 2015·Seminars in Immunology·Maria Rescigno
Mar 4, 2009·Expert Review of Anti-infective Therapy·Jean-Nicolas TournierBradley G Stiles
Mar 9, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rebecca J IngramDaniel M Altmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.